These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18455328)
21. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies. Gambacorta MA; Valentini V; Coco C; Morganti AG; Smaniotto D; Miccichè F; Mantini G; Barbaro B; Garcia-Vargas JE; Magistrelli P; Picciocchi A; Cellini N Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):139-48. PubMed ID: 15337549 [TBL] [Abstract][Full Text] [Related]
22. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. Rödel C; Grabenbauer GG; Papadopoulos T; Hohenberger W; Schmoll HJ; Sauer R J Clin Oncol; 2003 Aug; 21(16):3098-104. PubMed ID: 12915600 [TBL] [Abstract][Full Text] [Related]
23. Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study. Ofner D; Devries AF; Schaberl-Moser R; Greil R; Rabl H; Tschmelitsch J; Zitt M; Kapp KS; Fastner G; Keil F; Eisterer W; Jäger R; Offner F; Gnant M; Thaler J; Strahlenther Onkol; 2011 Feb; 187(2):100-7. PubMed ID: 21267531 [TBL] [Abstract][Full Text] [Related]
24. Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors. Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Samonis G; Vardakis N; Amarantidis K; Agelaki S; Mavroudis D; Xenidis N; Georgoulias V Oncology; 2004; 66(4):253-9. PubMed ID: 15218291 [TBL] [Abstract][Full Text] [Related]
25. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. Sym SJ; Ryu MH; Kang HJ; Lee SS; Chang HM; Lee JL; Kim TW; Yook JH; Oh ST; Kim BS; Kang YK Cancer Chemother Pharmacol; 2010 Jul; 66(2):373-80. PubMed ID: 19936751 [TBL] [Abstract][Full Text] [Related]
26. A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction. Malik I; Bernal P; Byrd J Cancer Invest; 2010 Oct; 28(8):833-8. PubMed ID: 20839949 [TBL] [Abstract][Full Text] [Related]
27. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Saif MW; Lansigan F; Ruta S; Lamb L; Mezes M; Elligers K; Grant N; Jiang ZL; Liu SH; Cheng YC Phytomedicine; 2010 Mar; 17(3-4):161-9. PubMed ID: 20092990 [TBL] [Abstract][Full Text] [Related]
28. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. Dunst J; Reese T; Sutter T; Zühlke H; Hinke A; Kölling-Schlebusch K; Frings S J Clin Oncol; 2002 Oct; 20(19):3983-91. PubMed ID: 12351595 [TBL] [Abstract][Full Text] [Related]
29. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. Comella P; Natale D; Farris A; Gambardella A; Maiorino L; Massidda B; Casaretti R; Tafuto S; Lorusso V; Leo S; Cannone M Cancer; 2005 Jul; 104(2):282-9. PubMed ID: 15948167 [TBL] [Abstract][Full Text] [Related]
30. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336 [TBL] [Abstract][Full Text] [Related]
31. Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial. Heudel P; Romestaing P; Barbet N; Falandry C; You B; Glehen O; Freyer G Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):369-74. PubMed ID: 18406583 [TBL] [Abstract][Full Text] [Related]
32. Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. Morganti AG; Picardi V; Ippolito E; Massaccesi M; Macchia G; Deodato F; Mattiucci GC; Caravatta L; Di Lullo L; Giglio G; Tambaro R; Mignogna S; Caprino P; Ingrosso M; Sofo L; Cellini N; Valentini V Acta Oncol; 2010 May; 49(4):418-22. PubMed ID: 20397772 [TBL] [Abstract][Full Text] [Related]
33. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. Zampino MG; Magni E; Leonardi MC; Petazzi E; Santoro L; Luca F; Chiappa A; Petralia G; Trovato C; Fazio N; Orecchia R; Nolè F; de Braud F Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):421-7. PubMed ID: 19211200 [TBL] [Abstract][Full Text] [Related]
34. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. Jansen EP; Boot H; Saunders MP; Crosby TD; Dubbelman R; Bartelink H; Verheij M; Cats A Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1424-8. PubMed ID: 17689023 [TBL] [Abstract][Full Text] [Related]
35. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Ngan SY; Michael M; Mackay J; McKendrick J; Leong T; Lim Joon D; Zalcberg JR Br J Cancer; 2004 Sep; 91(6):1019-24. PubMed ID: 15305186 [TBL] [Abstract][Full Text] [Related]
36. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844 [TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study. Akgun Z; Saglam S; Yucel S; Gural Z; Balik E; Cipe G; Yildiz S; Kilickap S; Okyar A; Kaytan-Saglam E Cancer Chemother Pharmacol; 2014 Oct; 74(4):751-6. PubMed ID: 25102935 [TBL] [Abstract][Full Text] [Related]
38. Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. O'Connell MJ; Colangelo LH; Beart RW; Petrelli NJ; Allegra CJ; Sharif S; Pitot HC; Shields AF; Landry JC; Ryan DP; Parda DS; Mohiuddin M; Arora A; Evans LS; Bahary N; Soori GS; Eakle J; Robertson JM; Moore DF; Mullane MR; Marchello BT; Ward PJ; Wozniak TF; Roh MS; Yothers G; Wolmark N J Clin Oncol; 2014 Jun; 32(18):1927-34. PubMed ID: 24799484 [TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339 [TBL] [Abstract][Full Text] [Related]
40. Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092). Valentini V; De Paoli A; Gambacorta MA; Mantini G; Ratto C; Vecchio FM; Barbaro B; Innocente R; Rossi C; Boz G; Barba MC; Frattegiani A; Lupattelli M; Doglietto GB Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):644-9. PubMed ID: 18395356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]